US Edition
SIO’s ACCLAIM Trial Completes Enrollment - Endovascular Today
Summary by Endovascular Today
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
SIO’s ACCLAIM Trial Completes Enrollment - Endovascular Today
August 5, 2025—The Society of Interventional Oncology (SIO) recently announced the completion of enrollment for its clinical trial, ACCLAIM—Ablation With Confirmation of Colorectal Liver Metastases. This milestone was achieved 8 months ahead of schedule, noted SIO. According to the society, the ACCLAIM trial enrolled 240 patients (330 tumors) diagnosed with colorectal cancer liver metastases. The study was conducted in collaboration with nine le…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
